Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis

Summary

The purpose of this study is to compare the safety and efficacy profiles of Tazarotene Cream, 0.05% and Tazorac® (Tazarotene) Cream, 0.05% in order to demonstrate bioequivalence and to demonstrate the superiority of the 2 active creams over that of the Vehicle (placebo) in the treatment of plaque psoriasis.

Timeline

Start

2014-05

Primary completion

2016-05

Completion

2016-05

Drugs

Indications